MRX Stock Overview
Provides and markets eyewear products in Germany and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Mister Spex SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.29 |
| 52 Week High | €4.20 |
| 52 Week Low | €2.60 |
| Beta | 1.69 |
| 1 Month Change | 14.24% |
| 3 Month Change | -16.39% |
| 1 Year Change | -5.87% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -86.57% |
Recent News & Updates
Shareholder Returns
| MRX | DE Specialty Retail | DE Market | |
|---|---|---|---|
| 7D | 11.5% | 1.4% | -0.8% |
| 1Y | -5.9% | -6.2% | 3.2% |
Return vs Industry: MRX matched the German Specialty Retail industry which returned -6.1% over the past year.
Return vs Market: MRX underperformed the German Market which returned 3% over the past year.
Price Volatility
| MRX volatility | |
|---|---|
| MRX Average Weekly Movement | 6.6% |
| Specialty Retail Industry Average Movement | 6.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.6% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: MRX's share price has been volatile over the past 3 months.
Volatility Over Time: MRX's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 1,293 | Dirk Graber | corporate.misterspex.com |
Mister Spex SE provides and markets eyewear products in Germany and internationally. It purchases and sells prescription glasses, sunglasses, and contact lenses. The company offers its products under the independent labels, own labels, and various premium and luxury brands through online shops and retail stores, as well as a network of partner opticians.
Mister Spex SE Fundamentals Summary
| MRX fundamental statistics | |
|---|---|
| Market cap | €112.11m |
| Earnings (TTM) | -€49.43m |
| Revenue (TTM) | €228.95m |
0.5x
P/S Ratio-2.3x
P/E RatioIs MRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRX income statement (TTM) | |
|---|---|
| Revenue | €228.95m |
| Cost of Revenue | €173.61m |
| Gross Profit | €55.35m |
| Other Expenses | €104.78m |
| Earnings | -€49.43m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 29, 2024
| Earnings per share (EPS) | -1.45 |
| Gross Margin | 24.17% |
| Net Profit Margin | -21.59% |
| Debt/Equity Ratio | 0.7% |
How did MRX perform over the long term?
See historical performance and comparison